Invesco’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-63,537
Closed -$193K 3822
2024
Q4
$193K Buy
63,537
+7,125
+13% +$21.7K ﹤0.01% 3508
2024
Q3
$293K Sell
56,412
-6,271
-10% -$32.5K ﹤0.01% 3412
2024
Q2
$161K Buy
62,683
+11,749
+23% +$30.2K ﹤0.01% 3665
2024
Q1
$251K Sell
50,934
-1,551,688
-97% -$7.63M ﹤0.01% 3562
2023
Q4
$14.1M Sell
1,602,622
-1,299,818
-45% -$11.4M ﹤0.01% 1603
2023
Q3
$33.3M Buy
2,902,440
+1,153,615
+66% +$13.2M 0.01% 1121
2023
Q2
$44.3M Buy
1,748,825
+1,527,259
+689% +$38.7M 0.01% 991
2023
Q1
$7.14M Buy
221,566
+155,131
+234% +$5M ﹤0.01% 2037
2022
Q4
$1.23M Sell
66,435
-174,255
-72% -$3.22M ﹤0.01% 2827
2022
Q3
$6.5M Buy
240,690
+177,802
+283% +$4.8M ﹤0.01% 2052
2022
Q2
$869K Sell
62,888
-155,458
-71% -$2.15M ﹤0.01% 3027
2022
Q1
$4.26M Buy
218,346
+178,955
+454% +$3.49M ﹤0.01% 2439
2021
Q4
$643K Sell
39,391
-2,683
-6% -$43.8K ﹤0.01% 3247
2021
Q3
$1.17M Buy
42,074
+5,377
+15% +$150K ﹤0.01% 3013
2021
Q2
$1.09M Buy
36,697
+10,012
+38% +$297K ﹤0.01% 3075
2021
Q1
$746K Buy
26,685
+12,665
+90% +$354K ﹤0.01% 3155
2020
Q4
$398K Sell
14,020
-21,945
-61% -$623K ﹤0.01% 3280
2020
Q3
$904K Buy
35,965
+4,288
+14% +$108K ﹤0.01% 2858
2020
Q2
$773K Buy
+31,677
New +$773K ﹤0.01% 2913
2020
Q1
Sell
-11,866
Closed -$193K 3687
2019
Q4
$193K Sell
11,866
-768
-6% -$12.5K ﹤0.01% 3485
2019
Q3
$164K Sell
12,634
-492
-4% -$6.39K ﹤0.01% 3529
2019
Q2
$170K Sell
13,126
-5,981
-31% -$77.5K ﹤0.01% 3591
2019
Q1
$301K Buy
+19,107
New +$301K ﹤0.01% 3464
2018
Q2
Sell
-83,097
Closed -$2.56M 3896
2018
Q1
$2.56M Buy
+83,097
New +$2.56M ﹤0.01% 2395
2016
Q2
Sell
-69,594
Closed -$1.22M 3698
2016
Q1
$1.22M Buy
+69,594
New +$1.22M ﹤0.01% 2798
2015
Q3
Sell
-161
Closed -$5K 3994
2015
Q2
$5K Buy
+161
New +$5K ﹤0.01% 4223